The 11th Annual Biomarkers & Diagnostics World Congress 2015 will be held May 5-7, 2015 in Philadelphia, Pennsylvania.
The event brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers.
The World Congress will continue offering comprehensive coverage of biomarkers, including translational biomarkers in drug discovery, patient selection biomarkers, strategies to co-develop drugs with companion diagnostics, as well as new coverage of big data for personalized medicine. New coverage of diagnostic applications will include cell-free DNA/RNA and exosomes, as well as clinical NGS as predictive cancer biomarkers.
The Congress includes the following primary tracks:
Please visit the Biomarkers & Diagnostics World Congress 2015 website for more information and to register.